IVC says the new brand will allow better communication for equine teams within the IVC Evidensia group as well as collaboration with the wider equine world.
IVC Evidensia Equine Vets range from graduates to European Specialists, working in both dedicated equine and mixed practice, with all practices supported by the four large equine veterinary referral hospitals in the UK: Donnington Grove Veterinary Group, Fyrnwy Equine Group, Oakham Veterinary Hospital and Pool House Equine.
IVC says the brand's mission is to put the welfare of horses at the heart of everything it does, to providing outstanding continuity of care for all equine species and breeds across the network, to be at the forefront of continual professional development, supporting and facilitating the development of clinical and leadership skills across all their equine teams, and to build the leading network for equine veterinary care across Europe.
Richard Stephenson, Chair of the IVC Evidensia Equine Clinical Board, said: "Our network brings together all forms of equine work from ambulatory practice to some of leading UK equine referral centres.
“It gives support to all our staff in their careers. We facilitate clinical development from the graduate academy, through intern training, residencies and training up to European Diplomat level.
“We provide coaching and leadership, flexible roles and friendly, inclusive teams.”
For more information, visit https://www.ivcevidensia.co.uk/Equine or stand B01 at BEVA 2021 congress.
According to the company, coprophagia affects 23% of dogs, with 16% being repeat offenders.
Copro-nil is a powder which, when added to food, makes the resultant faeces unpalatable. This, says the company, breaks the coprophagia habit and gives the owner an opportunity to implement training to eradicate the behaviour long-term.
Copro-nil has been relaunched in smaller 100g pots with a new look designed to make the product more appealing.
The product comes with advice about behavioural training methods to help owners understand how they can break the coprophagia habit in the long term.
Will Peel, product manager at TVM UK said: "The new format and packaging have been designed to help deal with this very unpleasant problem which many owners believe is a behaviour that dogs will grow out of.
"The new format is intended to demonstrate that Copro-nil, combined with effective behavioural training, can help resolve the problem effectively.’
Copro-nil also provides a comprehensive B vitamin source as deficiencies in B vitamins may contribute to coprophagia.
Downloadable advice sheets for veterinary staff to share help and advice with clients are available from www.tvm-uk.com/coprophagia.
João, who graduated from Portugal’s Oporto University in 2009, was recruited from the University of Liverpool, where he was a lecturer in Small Animal Cardiology.
Willows Clinical Director Toby Gemmill said: "This is an exciting time for us. As part of our new extension, our state-of-the-art cardiology suite is now open and fully operational, while we have also appointed a hugely knowledgeable and experienced cardiologist to join the team.
"It is further evidence of our continued commitment to invest in top talent and the best facilities so we can provide the highest standards of care and treatment."
João said: "I’m very pleased to have joined a centre of excellence like Willows and to be working in the fantastic new cardiology suite.
"I enjoy all aspects of medical and interventional cardiology but I have a particular interest in feline cardiomyopathies, cardiorenal syndrome and atrial fibrillation."
Severn Edge was formed six years ago with the merger of two long-standing neighbouring practices, and now employs 135 people, including 43 veterinary surgeons.
Mrs Karyn MacKenzie, Director of CVS’ Practice Division, said: "Severn Edge is an impressive practice with an outstanding leadership team and an ambitious and exciting vision for the future which we share. We are delighted to welcome the team to CVS and look forward to working with them to help them build an even more successful future."
Dr John Brentnall BVSc MRCVS, a Director of Severn Edge, will continue in the role of CVS Regional Director. He said: "It was clear from our early discussions that CVS understood what we are trying to achieve. We have embarked on a significant investment programme, including upgrading our surgery at Madeley outside Telford, and the redevelopment of the site of an additional clinic which we have recently acquired in Craven Arms.
"In order for us to continually upgrade our clinics, provide the widest range of career opportunities for our staff and steer our practice through an increasingly competitive world, we believe that the best interests of us all lie in joining forces with CVS. It is known for its interest in equine and farm practice, as well as companion animal practice, and has a policy of significant investment in both infrastructure and staff. We believe it offers the best fit with Severn Edge."
The course counts for four hours CPD, split into six short sessions which can be completed in your own time.
Presented by Dr Dan Cripwell BSc (Hons) BVSc CertAVP PgCert (VPS) MRCVS, Advanced Veterinary Practitioner and senior veterinary technical advisor at Jurox, the sessions consist of:
There is a quiz at the end of each module, following which, you can download a CPD certificate.
Suzy Ramsay, head of sales and marketing at Jurox (UK) Limited, said: “We are committed to developing unique and world class anaesthesia and analgesic products and practices within the animal health industry through the provision of up-to-date technical support and education. Our new Jurox Anaesthesia Academy CPD platform will enable veterinary professionals to adopt an evidence-based approach to their anaesthetic product choice and, in turn, help achieve the best possible anaesthetic outcomes for their patients.”
For access to the Jurox Anaesthesia Academy CPD platform, visit https://cpd.jurox.co.uk.
For further information, contact your local Jurox account manager, phone 0800 500 3171 or email customerservice@jurox.co.uk.
The publishers say that many people who prescribe veterinary medicines or who handle them (or bodily fluids that may contain them or their active metabolites) are not aware of the potential harmful effects they can have on human reproduction.
'Handling Veterinary Medicines and Pregnancy' gives up-to-date, evidence-based guidance on which drugs and methods of handling are hazardous; information on the relevant regulations relating to the safe handling of such medicines; and practical guidance on avoiding harm in veterinary practice.
Veterinary Prescriber says that once you have completed the module, you will:
understand the principles of reproductive toxicity
understand how data on the harmful effects of medicines are generated
be aware of the evidence on reproductive harm in veterinary practice
understand what practical measures to take to avoid harm
know where to find helpful information on medicines and pregnancy
For more information, visit: https://www.veterinaryprescriber.org/subscribers/
Dechra Veterinary Products has announced that Intubeaze Oromucosal Spray is now back in stock.
Intubeaze is used for local anaesthesia of the laryngeal mucosa of cats to facilitate endotracheal intubation by preventing the stimulation of the laryngeal reflex.
The product had gone out of stock due to a temporary manufacturing problem which has now been fixed.
Intubeaze is a clear solution containing 2% w/v lidocaine hydrochloride, with 0.1% w/v chlorocresol as an antimicrobial preservative. Intubeaze is now available through all wholesalers.
For further information on Intubeaze please contact Dechra on 01743 441 632 or visit www.dechra.co.uk.
Dr Stephen Hearns, a consultant in aeromedical retrieval (human) medicine, who delivers pre-hospital critical care for major trauma patients, will open Congress as the keynote speaker.
He'll also present a limited-seat session where he’ll focus on performance under pressure.
Joining Stephen in the speaker line up are Simon Cook from the RVC, Megan Brashear from Purdue University Veterinary Hospital, Tim Travail, Chloe Fay, Dan Tipney, Jenny Guyat, Ashton Hollworth and Dr Craig Joyce, an educational psychologist who will be offering his insights into dealing with imposter syndrome.
This year, participants will have the opportunity to follow a trauma case from arrival to departure on the first day of Congress, gaining real-time insights into the decision-making process and management strategies.
On day two, speakers will delve into lessons learned, allowing attendees to deepen their understanding of emergency and critical care practices
Simon said: “Get ready for a fantastic speaker line-up, an array of workshops and learning experiences, a bustling exhibition hall and more opportunities than ever for veterinary and nursing delegates to reconnect with old friends and make new ones.
"Brace yourselves to absorb knowledge and tips from some of the world’s leading veterinary experts discussing emergency and critical care.”
The ECC Congress programme for 2023 is open to veterinary professionals of all levels, including veterinarian surgeons, vet nurses, students and graduates.
Tickets range in price from £50+ VAT for exhibition-only tickets, up to £520+ VAT for a vet to attend for 2 days plus the Gala dinner.
https://www.vets-now.com/congress/
Omniotic combines three ingredients to remove ear wax and debris: a detergent, a solvent and an emulsifier. It also contains Octoxynol-9, lactic acid, salicylic acid and parabens, which Vita says have anti-fungal, anti-viral and anti-bacterial properties.
The product is sold in 120ml bottles with a transparent flexible tip designed to be comfortable even in stenosed, tender ear canals.
Omniotic can be used for regular daily cleaning, especially in predisposed breeds such as spaniels and lop-eared rabbits where ear conformation increases the risk of ear disease.
The product can also be used alongside other antibiotics or anti-fungal medications, something which Vita highlights as being especially important in rabbits, the ear canals of which are less prone to inflammation and stenosis, and for which topical treatment can be very effective.
Tara Evans, RVN and sales manager said: "Omniotic is an ear cleaner for dogs, cats and rabbits which combines features to meet the needs of owners and vets at the same time. The feedback from our customers is very positive; they are finding the soft, flexible applicator tip is easy to use and well tolerated. The unique combination of ingredients and the multi-species use means Omniotic can be used to support ear health across a wide variety of indications."
For more information and for the latest promotional offers, contact Tara Evans, via email: info@vitaanimalhealth.com, or telephone: 01256 591032.
The authors say that an association between acute kidney injury and general anaesthesia is well-defined in human medicine, but there is little information in the veterinary literature.
In their new study, called “Twelve previously healthy non-geriatric dogs present for acute kidney injury after general anaesthesia for non-emergency surgical procedures in the UK1”, Emma Rogers-Smith and her co-authors retrospectively analysed the medical records of 12 dogs that presented for acute kidney injury following general anaesthesia across three multidisciplinary referral centres and one primary care practice in the UK. Information obtained included signalment, general anaesthesia, surgical procedure and peri-surgical management.
The aim was to characterise common factors after a suspected increase in incidence of post-procedure acute kidney injury in animals without identifiable risk factors.
Emma Rogers-Smith, a resident in internal medicine at Davies Veterinary Specialists and corresponding author for the paper, said: “A suspicion that there was an increase in non-geriatric dogs suffering acute kidney injury (AKI) shortly after elective procedures led to this study.
"Whilst our data supported this suspicion, there was an increase in incidence, the change itself is not statistically significant and so we are unable to be conclusive.
"This study is limited by small sample size and retrospective nature of the data. At this time no definitive causal link between these cases has been found.
"As such, we are urging clinicians with similar experiences in the last 24 months to get in touch. We hope to ascertain if there is any commonality between these cases and, if possible, better define the incidence of AKI in non-geriatric animals following elective procedures.”
Nick Jeffery, editor of JSAP said: “Nowadays, most veterinarians consider general anaesthesia safe in dogs and routinely allay pet-owner concerns. Whilst AKI following general anaesthesia seems to be rare, it is worrying that a specific risk factor was not identified in any dog, despite a wealth of available clinical data. I would urge any veterinarians that have similar cases to contact the authors.”
Any clinicians with similar experiences during the last 24 months should contact Emma Rogers-Smith on emma.rogers-smith@vetspecialists.co.uk.
The full article can be found in the June issue of the Journal of Small Animal Practice, and here: https://www.onlinelibrary.wiley.com/doi/10.1111/jsap.13134
Reference
Dr Neil Bryant from the AHT, who is leading the research, said: "EHV is a major welfare concern for horses and foals and causes emotional, as well as financial strains, on horse owners and breeders around the world. It can strike any horse at any time so a vaccine will be of global welfare benefit to all horses, including the thoroughbred and sports horse breeding industries, and would help control this serious and sometimes fatal disease."
As a viral infection, EHV can cause respiratory disease, abortion or fatal illness in new born foals and neurological disease in adult horses, with signs ranging from slight wobbliness through to complete paralysis. The disease can strike any horse at any time because the virus, like other herpesviruses (such as the cold sore virus in humans), becomes dormant within most horses early in their life. It then re-emerges when the animal is later stressed such as when transported or mixed with new horses. A seemingly healthy pregnant mare may suddenly, and without warning, abort her unborn foal or may show signs of respiratory disease including mild fever, coughing and discharge from the nose. A horse which appears fit and well may suddenly show abnormalities when walking and within hours may be unable to stand.
Despite the potential severity and impact of outbreaks, there is still no vaccine that is licensed to protect against the neurological form of the disease and abortions still occur in highly vaccinated horse populations. The AHT says protection afforded by existing vaccines currently in use is sub-optimal, something that was highlighted by the 2016 abortion storm in Hertfordshire in fully vaccinated animals.
Neil added: "We have become aware of a pressing need for progress towards a new and improved EHV-1 vaccine. Just last month, the AHT was again called upon to work with the racing industry and affected parties in dealing with confirmed cases of EHV-1 abortion in premises in Yorkshire and Suffolk."
To that end, the charity has now established the Equine Industries EHV Vaccine Steering Group. Chaired by Professor Joe Brownlie of the RVC, the steering group includes world-renowned experts on both human and equine herpes viruses from a number of research establishments, who have concluded that the most appropriate way forward is for the AHT to design a modified live virus (MLV) vaccine.
After securing funding from a large number of organisations, including the Alborada Trust, EBM Charitable Trust, Horserace Betting Levy Board and the Racing Foundation, Paul Mellon Estate, Thompson Family Charitable Trust, Coolmore Ireland, Newsells Park Stud, Thoroughbred Breeders’ Association and Juddmonte Farms, the AHT has begun its five-year research programme.
Neil added: "We’re at the beginning of a very exciting and potentially ground-breaking vaccine development. Through our research, we will construct different viruses with attenuating mutations and assess their suitability as MLVs. We hope our findings will enable further development by vaccine manufacturers in creating an effective vaccine to protect against the serious clinical signs induced by EHV-1."
Vetswest, the veterinary support services company, has been acquired by MWI Veterinary Supply, a subsidiary of the US multinational, AmerisourceBergen.
MWI already owns Centaur and VetSpace, and the agreement will allow it to further expand the range of services it offers the animal health profession in the UK.
Jim Cleary, Executive Vice President of AmerisourceBergen and President of MWI Veterinary Supply said: “This partnership reflects our commitment to the success of veterinary practices across the globe. We’re proud to welcome Vetswest to the MWI family as we continue to expand our services in our mission to be the best resource to the animal health profession.”
Vetswest offers group business support services for its 235 member veterinary practices including negotiating manufacturer terms and a proprietary IT system that supports pricing intelligence, inventory information and reporting on purchasing activity. The company also provides access to ancillary services for veterinary surgeons to help manage human resources, continuing professional development, insurance offerings, pension services and other areas which support the growth of member practices.
Vetswest's retiring managing director David Buckley said: “The resources of MWI and AmerisourceBergen will allow us to bring new innovation to the market and additional benefits to Vetswest members. I’m excited about Vetswest’s future under the leadership of Chris Sobey and as part of the MWI and AmerisourceBergen family.”
Chris Sobey, who will become the new managing director of Vetswest following his tenure as Vetswest’s business development director said: “Our goal has always been to improve efficiencies and services for our members through scale and with our new relationship with MWI and AmerisourceBergen, we will be well positioned to further this core mission of our organisation.’’
At his first Disciplinary Committee hearing in January 2018, the Committee directed that Dr Gerhard Schulze Allen’s name be removed from the Register after finding him guilty of serious professional misconduct in respect of four charges against him. These related to an incident of petty theft in California in the United States, and his subsequent dishonesty in not disclosing this to the College.
Following the Disciplinary Committee hearing, Dr Schulze Allen submitted an appeal to the Privy Council. In July 2019, the Privy Council partially upheld his appeal, determining that the RCVS had not proven beyond all reasonable doubt that Dr Schulze Allen’s infraction for petty theft was a conviction under Californian law and therefore Dr Schulze Allen had not made false representations to the College when he said he did not have any criminal convictions or a criminal record.
However, the Privy Council partially upheld the College’s charge that Dr Schulze Allen was dishonest and made false representations when he had, in a written application for restoration to the Register, represented that he did not have any adverse findings and that he should have declared his infraction for petty theft. The Privy Council also set aside the Disciplinary Committee’s original sanction and remitted the task of sanction back to the Disciplinary Committee.
As a result of the Privy Council’s decision, the Disciplinary Committee held a further hearing in relation to Dr Schulze Allen to decide the sanction in relation to the upheld charge against him.
The Committee noted that the aggravating factors were the fact that Dr Schulze Allen was dishonest to his regulator and in making a false declaration, demonstrated a wilful disregard for the regulatory role of the RCVS. In mitigation the Committee considered that there was no harm to animals, that it was a single and isolated incident in an otherwise unblemished career, and that he had accepted his wrongdoing, albeit at a late stage, and was developing some insight.
The Committee considered whether a reprimand or warning would be the most appropriate sanction but determined that this would not reflect the seriousness of the dishonesty in this case, nor maintain public confidence in the profession or uphold proper professional standards of conduct and behaviour.
Ian Green, chairing the Committee and speaking on its behalf, said: "The Committee concluded that the appropriate and proportionate sanction is suspension from the Register for a period of three months. A period of three months reflects the seriousness of the charge. Such a sanction sends a clear message to Dr Schulze Allen, the profession and the public that behaving dishonestly towards the regulator is a serious matter. The Committee considered that removal from the Register would be disproportionate given that this is a single incident and Dr Schulze Allen now accepts his wrongdoing."
To take part in the survey, which will take about ten minutes, visit: https://www.surveymonkey.co.uk/r/RepRIPorVIP.
Everyone who completes the survey will be entered into a draw to win one of three £50 Amazon vouchers.
The House of Lords debate, which is being hosted by Professor The Lord Tress of Kinross, will take place on Wednesday, 21st June 2023.
Speakers will include Donal Murphy of NOAH, Rita Dingwall of the Federation f Independent Veterinary Practices and Paul Horwood, Country Head of Farm at IVC Evidensia.
https://vma.org.uk/house-of-lords/
Charcovet Gel contains 30g of activated charcoal in a 60ml syringe.
Dr John Henderson, Large Animal Product Manager at Forte Healthcare said: “In young animals with digestive disturbances, Charcovet Gel uses the adsorbent properties of activated charcoal to support the gut in a return to normal function.
"The value of using activated charcoal in cases of digestive upset in young animals has long been recognised, but the difficulty and mess involved in mixing such a fine dry powder in water presented considerable usability issues.
"With Charcovet Gel, the appropriate volume of activated charcoal gel is simply selected from the graduated syringe and administered directly into the animal’s mouth.
"Charcovet Gel can be given daily as needed to support the animal during the period of digestive upset.”
Each box of Charcovet Gel contains 12 syringes.
Charcovet Gel is available now from all major veterinary wholesalers, or directly from Forte Healthcare Ltd.
For more information contact your Forte Territory Manager, email enquiries@fortehealthcare.com or visit: https://www.fortehealthcare.com/product/charcovet-gel
Tony Noble, managing director at Noble Futures, said: "We have been working with organisations of all shapes and sizes since our foundation in 2002 and it became clear that while we can ensure that our clients recruit the top people for the job - through finding them the best permanent, contracting or temporary employees - the resources are not always present to ensure that this human resource potential is maximised. The team at The Partners deliver a world-class service and we are 100% confident that their professional and expert support services will make a real difference to our clients’ businesses."
Noble Futures and The Partners have launched three new services:
The Human Resources support service is aimed at organisations that need additional support or more expert advice within the human resources function, whether it relates to a particular employee issue such as managing a long-term illness, or a wider corporate challenge like implementing a company-wide performance management system.
The Psychometric Profiling service is designed to give unique insights into the individual traits of employees, to help with recruitment, promotion, coaching and career development.
Finally, the Management Development service has been developed to help ensure a company’s employees receive the right training for success.
Paula Summerscales (pictured right with husband Graham) from The Partners said: "We are delighted to partner with Noble Futures to deliver our range of people-building services to organisations in the animal health sector. Our unique mix of skills and experience allows us to bring a tailored approach to every single project we work on and we’re looking forward to working with Noble Futures clients to implement innovative solutions that gain commercial results."
For more information, contact Noble Futures on 0161 820 3510 or email: info@noble-futures.com.
Alternatively, contact The Partners directly on 01484 860849
RSPCA has launched a new website called 'Political Animal' to encourage voters to lobby their prospective parliamentary candidates about animal welfare issues ahead of the General Election.
The site offers an interesting timeline of the last 20 years of animal welfare law, leading up to the Animal Welfare Act 2006, showing landmark changes. It also gives details of the RSPCA's stance on issues like status dogs, higher welfare farming, wild animals in circuses and animals used in experiments.
RSPCA parliamentary officer Stacey Frier, said: "The Political Animal microsite is a unique project allowing our supporters to drive the debate by letting politicians know what they want them to do for animal welfare if they are elected.
"The RSPCA and its supporters have been instrumental in campaigning for change in animal welfare legislation since the Society's creation in 1824 and we're urging the incoming parliament to continue to work with us to achieve further animal welfare milestones."
For more information, please log on to http://www.politicalanimal.org.uk/
The aim of the study was to assess the efficacy and adverse effect profile of each individual AED by analysing all available data published and then evaluating how reliable it was.
The researchers gathered, screened and assessed all the information published in peer-reviewed journals and publications. The individual studies were then evaluated based on the quality of evidence, study design, study group sizes, subject enrolment quality and overall risk of bias, as well as the efficacy and safety outcome measures.
Lead-author, Marios Charalambous from Ghent University, said: "We recruited systematic methods to combine, compare and summarise the results of independent studies and, therefore, create more objective and reliable conclusions based on the current evidence. It was a time-consuming, demanding and challenging process, and we hope we provided the clinicians now with essential information which they can use for daily practice."
The researchers found that much of the evidence for the medical treatment of feline epilepsy was based on below-par reporting of efficacy and adverse effect, worse than what was formerly reported in dogs.
The lack of good quality evidence led authors to conclude that it would be: "...rather inaccurate to make definite statements on which one [AED] should be considered as a first or second choice in terms of both efficacy and safety profile. However, if clinicians focus on AED’s efficacy, phenobarbital can be used as first-choice monotherapy and if they focus on AED’s safety, imepitoin or levetiracetam can be used."
Holger Volk, Head of the Department Clinical Science and Services and Professor of Veterinary Neurology and Neurosurgery at the RVC, said: "Not only does this study offer a new perspective on the management of feline epilepsy, but also highlights the importance of the need for trials which provide high quality evidence in order to have more reliable and objective results about the efficacy and safety of the AEDs in feline epilepsy."
The study was published in BMC Veterinary Research (https://doi.org/10.1186/s12917-018-1386-3).
The study looked at the anonymised employment data of 1,642 veterinary nurses working across 418 UK primary-care companion animal veterinary practices at the end of 2020, including both qualified and student nurses.
Of these, 278 (16.9%) nurses resigned from their veterinary practice between 1 January to 31 December 2021.
Career progression was cited as a reason for resigning by 36.7%, compared to 12.9% for personal reasons, 11.9% for better pay, 10.1% for a better work-life balance, 6.8% to relocate, and 3.6% decided not to return after parental leave.
The research also looked at factors associated with lower odds of future nurse resignations.
They included longer employment tenure (p < 0.001) and working at practices with greater property and facilities ratings (p < 0.049).
Head nurses and students were least likely to resign, whereas by comparison, the nurse role was associated with resignations (p = 0.008), adding to the evidence to support nursing career pathways.
The employee engagement metric, eNPS, was also identified as a reliable indicator of nurse retention. reflecting similar findings in other healthcare professions.
Imogen Schofield, Veterinary Statistician and Epidemiologist at CVS, said: “We want to support the whole industry in reducing the number of nurses leaving their roles and the profession.
"Little objective industry data is available on the true reasons behind nurse attrition and we believe this is the first study to outline the risk factors for nurse resignations using practice data, providing an important addition to the evidence-base surrounding this complex topic.
“Reflecting on our research, that was based on data in 2021, we have since seen our attrition rate fall and our employee engagement measure increase as we have focused on developing career pathways, empowering nurses to take on more responsibilities; developing a range of wellbeing programmes, launching a variety of colleague benefits, and significantly investing in our practices.”
A 2012 RVC graduate, Daniella is the Principle Exotics Vet at ParkVet Hospital and is studying towards a certificate in Zoological Medicine. She said: "Despite their amazing work, the AWF struggles for funds to continue its vital work, so I have decided not only to be the first ever person to run the London Marathon for the AWF, but to run it in costume!
"Those who know me will be aware that running is not among my favourite activities, but I am stepping up to the challenge to raise much-needed funds for this fantastic charity that’s making a real, tangible difference to animals worldwide."
"Working full time in clinical practice, including being part of an out-of-hours rota, means training must be factored in with military precision: so far, some of my longer runs are planned for 4 am!
"I also entered the Hastings Half Marathon on 18 March, and my final training run prior to the big day is scheduled for when I will be in Queensland, Australia for my brother’s wedding.
"If I can manage 22 miles in those hot and humid conditions, the London Marathon should be a breeze!”
Chris Laurence. AWF Chair of Trustees, said: "I am delighted that Daniella has chosen to raise funds for AWF in what is arguably one of the biggest sporting events in the world. On behalf of the organisation, I’d like to thank her for her support and wish her all the best for the marathon."
To support Daniella’s fundraising, visit: https://uk.virginmoneygiving.com/DaniellaDosSantos
For updates on her training and to find out more about AWF, visit www.bva-awf.org.uk
Petplan has announced that Richard Williams MRCVS from the Vale Veterinary Centre in Barry has won its Vet of the Year award.
The award is one of a number handed out each year to celebrate exceptional veterinary surgeons, nurses, practices, practice managers and vet support staff who have gone above and beyond the call of duty in keeping pets healthy and giving owners peace of mind.
The independent panel of judges was particularly impressed with Richard’s tireless dedication to veterinary care. They said: "He is considered by both clients and colleagues to be a great communicator, is constantly researching new and improved techniques, is brilliant at motivating staff and proactively encourages the professional development of his team – he truly leads by example."
On receiving the award, Richard said: "I’m completely surprised, overjoyed and humbled that my clients have taken the time out of their busy days to vote. It’s a great feeling."
Other winners included:
Isabella von Mesterhazy, Head of Marketing at Petplan, said: "Through the annual Petplan Veterinary Awards we’re able to pay tribute to the incredible work carried out by members of the veterinary profession across the UK. Their dedication allows pet owners to rest safe in the knowledge that, whether it’s for a routine check-up, an unexpected illness or injury or a simple procedure, their much-loved pets are in safe hands when they visit their vets. We’re elated to be able to announce the deserving winners, and congratulate them on such a fantastic achievement!"
For more information about the awards and to learn more about the winners, please visit http://www.petplan.co.uk/vetawards/winners.asp.
Ian graduated from the University of Liverpool and gained his PhD from the University of Glasgow. He gained both the UK and European Diplomas in Small Animal Medicine at the University of Cambridge and is a Royal College of Veterinary Surgeons and European Recognised Specialist in Small Animal Medicine. He returned to Glasgow University in 1998 and has been the Professor of Small Animal Medicine since 2009.
Ian has published in the fields of infectious diseases, endocrinology and neurology but is interested in all aspects of small animal medicine. In 2015 he was awarded the BSAVA Woodrow Award for his contribution to small animal medicine. In 2016 he became of Fellow of the RCVS, thereby becoming a jolly good fellow Fellow of the RCVS, or JGFFRCVS for short.
Professor Ramsey has served BSAVA as a regional secretary, member of several committees and chair of Petsavers and Scientific. He is probably best known as the editor of four editions of the BSAVA Small Animal Formulary.
The Presidential handover usually takes place at BSAVA Congress but was delayed this year given the cancellation of the April event due to coronavirus.
Ian says that during his Presidency, he intends to promote and enhance the digital offering of the Association to BSAVA members coping with the pandemic. He will also oversee changes to BSAVA congress with a more interactive approach to training; shortened, more focussed lectures and greater integration between the exhibition, the scientific content, and the social events.
Ian said: “At this time of great uncertainty in the profession, my focus will be on providing BSAVA members with the scientific information and clinical training that they need, in a suitable form. Clinical skills and science lie at the heart of being a good vet and BSAVA members get access to a huge range of cheap or free resources in these areas to help them in their careers. Congress 2021 will be evolving as a vital part of this effort and I am looking forward to welcoming everyone to Manchester during the last week of March 2021."
Lots of April Fool's Day gags involving animals this year...
watch?v=1kC0OI9MYZc
The Sun reported that Sir Richard Branson's health club chain, Virgin Active, is launching a new gym for dogs only, to combat the pet obesity epidemic. Alton Towers supposedly launched a new rollercoaster ride for dogs only. Meanwhile, Pasante, a condom manufacturer, launched the 'condog', though this seems to be a variation on an idea that has been around for a while now.
My favourites, though, were two April fools unrelated to animals. The first was from Cadbury's, made more believable by the fact that it was planted in the Southampton Echo. The second was the announcement by BMW that Dr. Noit All, the company's Head of Innovation, had developed a fuel-saving system called Magnetic Tow Technology (MTT). Readers were invited to keep abreast with future developments from BMW by emailing Dr. Noit All's colleague at uve.vollenvorit@bmw.co.uk.
Andrew, who is head of dentistry and oral and maxillofacial surgery at Eastcott Referrals in Swindon simultaneously became an RVCS Specialist in Veterinary Dentistry.
Eastcott Referrals managing director Peter Southerden, who is also a recognised EVDC specialist in dentistry, said: "This is a terrific achievement by Andrew.
"He’s spent six years studying on the EVDC’s training programme which finally culminated in four days of intense examinations.
"He now joins just eight other veterinary dentists in the UK who are recognised by the EVDC."
Andrew is now planning to build on his qualifications. He said: "I aim to start studying again in January when I hope to begin a Fellowship of the American College of Veterinary Surgeons in oral and maxillofacial surgery.
"The Fellowship is overseen by the American College of Veterinary Surgeons (ACVS) and is a post-specialist qualification indicating further specialisation in maxillofacial surgery.
"It’s two more years of study, including the need for publication in an international journal, and then an exam in the US.
"The primary benefit is the continued development of my skills, insuring that, here at Eastcott, we are operating to the highest international standards and can treat patients with the most complex problems.
"Peter is an ACVS Founding Fellow in Oral and Maxillofacial Surgery, currently the only fellow of the ACVS in Europe, so I’m proudly following in his footsteps to become the first resident of the Fellowship in Europe.
"It shows our commitment to dental and maxillofacial work and we believe we are leading the way with our cutting-edge surgical procedures and innovations within our state-of the-art facilities.
"We are not just one of the foremost centres of excellence for this specialist work in the UK but throughout Europe, too."
Petplan has announced the results of a survey which shows that with less than a week to go before microchipping becomes compulsory in England, Scotland and Wales, there is still confusion about the law amongst pet owners.
In the survey of 2,000 British dog owners, 25% had not heard of the new law and 40% didn't know that it also requires owners to keep their microchip details up to date.
40% of respondents said they'd be happy to pay over £500 as a reward if their dog went missing. Despite this, 40% of those who were aware of the new law but had yet to chip their dogs admitted they had not done so because of reservations about the cost of the procedure.
The survey also highlighted the fact that even the most careful of owners lose their dogs. Nearly 40% of losses reported in the survey happened when the owner was taking their pet on a daily walk and 47.1% of respondents reported having a dog escape from an apparently secure garden.
The survey also found that a third of lost dogs came to harm while missing, most of which (84.8%) needed veterinary care.
According to Petplan, despite more than half of dog owners citing expensive veterinary bills as one of their biggest concerns around dog ownership, over 45% of respondents reported not having their dogs insured.
Petplan has published information for pet owners about the new microchip law here: petplan.co.uk/microchip-dog-law-info.